Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Jul 27, 2026
Why Is Calumet (CLMT) Stock Down -2.64% Today?

Why Is Calumet (CLMT) Stock Down -2.64% Today?

Key Takeaways

  • Calumet shares fell 2.64% on Friday, closing at $41.69, extending a two-day losing streak that has erased roughly 5.5% from the stock's value since Wednesday's close.
  • Profit-taking was the primary catalyst, as traders locked in gains following a blistering rally that saw the stock surge more than 109% year-to-date and touch a 52-week high of $45.20 intraday on Thursday.
  • Valuation concerns weighed on sentiment, with multiple analysts flagging the stock as overvalued relative to a widely cited fair value estimate of $38.80 amid thin margins and high leverage.
  • Broader market and energy-sector headwinds compounded the selling pressure, as crude oil prices retreated more than 4% on Friday and technology stocks dragged major indices lower.
  • Traders are now watching the upcoming Q2 earnings report scheduled for August 7 for clarity on operational momentum and the company's deleveraging progress.

Opening Summary

CLMT, the stock of Calumet, Inc. — an Indianapolis-based manufacturer and marketer of specialty branded products and renewable fuels — fell 2.64% in Friday's trading session, closing at $41.69, down $1.13 from the prior session's close of $42.82. The decline marked the second consecutive day of selling pressure after the stock hit a fresh 52-week high of $45.20 during Thursday's intraday trading, representing a sharp reversal from the euphoric rally that has propelled shares more than 109% higher year-to-date.

Profit-Taking After a Massive Rally

The most immediate driver behind the decline was straightforward profit-taking. CLMT has been one of the standout performers in the specialty chemicals and renewable fuels space this year, with shares rocketing from a 52-week low of $12.94 to as high as $45.20 — a gain of roughly 249%. Much of that enthusiasm was fueled by Calumet's early-July redemption of $100 million in 9.75% Senior Notes due 2028, a move that reinforced the company's commitment to deleveraging its heavily indebted balance sheet. Additionally, the MaxSAF 150 sustainable aviation fuel expansion project at its Montana Renewables subsidiary has captured investor imagination, promising to position Calumet as a key player in the fast-growing SAF market.

With those catalysts now largely priced in, traders used the mid-session Thursday reversal at the $45 level as a signal to lock in profits. Friday's session saw continued distribution, with volume of 1.42 million shares well above the average of roughly 983,000, indicating that institutional and retail sellers alike participated in the move.

Valuation Scrutiny and Fundamental Headwinds

Behind the selling sits a growing chorus of skepticism about Calumet's valuation. The stock's sharp ascent pushed its forward price-to-earnings multiple to approximately 61x, a demanding level for a company that reported a Q1 2026 net loss of $317 million — equivalent to earnings per share of negative $3.64, which badly missed analyst estimates of negative $0.57. The company's gross margins remain thin at roughly 7.4%, and its net debt-to-EBITDA ratio hovers around 7x, leaving limited room for error. With a consensus analyst price target of approximately $36.75 — representing a potential downside of roughly 12% from Friday's close — the market appears to be reassessing whether the growth story can justify the premium.

Broader Energy and Market Context

Calumet's decline did not occur in isolation. Crude oil prices tumbled more than 4% on Friday, with Brent retreating from above $100 per barrel to around $96, as traders booked profits from the week's geopolitical rally and reports emerged that China had initiated efforts to resume stalled peace talks between the United States and Iran. The pullback in crude weighed broadly on energy-linked equities, even as the sector had posted strong weekly gains. Meanwhile, U.S. equity markets struggled with their own crosscurrents: the S&P 500 finished essentially flat on Friday, but the Nasdaq Composite shed 0.64% as concerns over escalating AI capital expenditures continued to rattle technology stocks. The Dow Jones Industrial Average managed a 0.46% gain, but all three major indices closed the week in the red.

New tariffs imposed by the Trump administration on goods from 60 trading partners, combined with lingering anxiety over Middle East supply disruptions, created a risk-off undercurrent that likely accelerated profit-taking in high-momentum names like CLMT.

Market Context and Trading Activity

Friday's selloff was notable for its elevated volume, which came in roughly 45% above the 20-day average. The stock opened at $42.63, briefly pushed to an intraday high of $43.00, but ultimately slid to a session low of $41.17 before settling at $41.69. After-hours trading saw further erosion to $41.21, suggesting that selling pressure had not fully abated by the closing bell. Technically, the breach below $42 — a level that had served as support during the late-July consolidation — raises the possibility of a test of the 50-day moving average, which sits near $34. More broadly, CLMT remains well above its 200-day moving average of approximately $26.24, underscoring that the current pullback, while sharp, has not yet threatened the longer-term uptrend.

What Comes Next for CLMT

All eyes now turn to Calumet's second-quarter earnings report, scheduled for August 7, 2026. Investors will be scrutinizing whether the operational improvements flagged by management — including the restart of the Shreveport facility and the commencement of MaxSAF 150 operations — translated into improved cash flow and margin performance. The Q1 earnings call had framed the massive $317 million net loss as largely driven by non-cash mark-to-market items and RINs (Renewable Identification Numbers) adjustments, but bulls will need to see concrete evidence of progress on the bottom line to rekindle upward momentum.

Key risks include continued volatility in crude oil prices and refining margins, potential shifts in renewable fuel policy that could impact SAF economics, and the persistent challenge of a $2.3 billion long-term debt load against deeply negative shareholder equity. On the other hand, if crack spreads remain elevated and the specialty products segment continues to execute on its pricing strategy, the deleveraging narrative could regain traction. For now, the stock appears to be in a consolidation phase as the market digests the magnitude of its year-to-date gains.

Trending AI Robots

For traders seeking data-driven approaches to navigate volatile markets like the one affecting CLMT, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron provides hundreds of algorithmic trading bots covering thousands of tickers across multiple strategies, timeframes, and performance metrics, but only the strongest performers under current market conditions are featured in this dedicated section. Bots vary by strategy type — from swing trading to trend following to pattern recognition — enabling traders to identify automated approaches aligned with their risk tolerance and market outlook. Explore the Trending AI Robots page to discover which algorithms are generating the most compelling signals right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CLMT

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


CLMT in +6.48% Uptrend, advancing for three consecutive days on August 18, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CLMT advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 10, 2026. You may want to consider a long position or call options on CLMT as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CLMT just turned positive on August 12, 2026. Looking at past instances where CLMT's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 228 cases where CLMT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CLMT moved out of overbought territory on August 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CLMT broke above its upper Bollinger Band on August 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CLMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.001). P/E Ratio (27.068) is within average values for comparable stocks, (39.393). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.393). CLMT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.930) is also within normal values, averaging (70.976).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 12.06B. The market cap for tickers in the group ranges from 47 to 224.76B. LIN holds the highest valuation in this group at 224.76B. The lowest valued company is GTBT at 47.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 6%. CITR experienced the highest price growth at 21%, while LWLG experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 25%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 58
Price Growth Rating: 51
SMR Rating: 77
Profit Risk Rating: 81
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
CLMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of specialty hydrocarbon products

Industry ChemicalsSpecialty

Profile
Details
Industry
Industrial Specialties
Address
1060 N Capitol Avenue
Phone
+1 317 328-5660
Employees
1540
Web
https://www.calumet.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.